Slide 1: 2Q 2024 Summary
3Q 2023 2Q 2024Commentary Earnings Earnings Commentary Revenue Adjusted Diluted EPS 2Q 2024 Summary Adjusted Expense in millions CME Group’s strong performance in 2Q is evidence of our clients’ $1,600 $2.80 growing need for risk management driving record quarterly results • Achieved our highest ever
Slide 2: 2Q 2024 Highlights & Commentary
2Q 2024 Earnings Commentary - Unaudited 2Q 2024 Highlights & Commentary (ADV and OI stated in contracts, except for cash markets) Driven by the strong demand for our risk management products, we delivered the highest quarterly adjusted net income and adjusted diluted earnings per share in our histor
Slide 3: 2Q 2024 Product Detail: Commodities and Financials ADV
2Q 2024 Earnings Commentary - Unaudited Clients continued to turn to CME Group’s diverse product portfolio as ongoing market uncertainty and geopolitical factors drove growing demand for risk management across every asset class in 2Q24 Higher priced Commodities driving growth - 2Q24 Physical Commodi
Slide 4: FX and Options ADV Growth
2Q 2024 Earnings Commentary - Unaudited FX ADV up 20% to 1.1M with YoY growth in several currency pairs and 86% YoY growth for FX Link • Euro FX futures ADV up 6% to 237K • Quarterly record ADV across Canadian Dollar futures (+40%), Mexican Peso futures (+62%), New Zealand Dollar futures (+17%), and
Slide 5: 2Q 2024 Product Detail - Financials and Commodities
2Q 2024 Earnings Commentary - Unaudited The need for risk management at CME Group is more broad-based than ever • 2024 ADV continues to climb with the highest YTD ADV in history (as of July 22) of 25.9 million, up 6% overall and including year-to-date YoY growth across all 6 asset classes • So far i
Slide 6: Financial Results, Notes & Guidance
2Q 2024 Earnings Commentary - Unaudited Financial Results • 2Q24 revenue was a record $1.5 billion, up • As of June 30, the company had ~$2 billion in cash 13% versus 2Q23. 2Q24 clearing and (including $225 million deposited with Fixed Income Clearing transaction fees revenue totaled over $1.2 Corpo
Slide 7: Appendix: Micro Product Quarterly Details
2Q 2024 Earnings Commentary - Unaudited Financial Results Appendix Micro Product Quarterly Details ADV in thousands / RPC in cents except for Micro Crypto Micro Equity Index Products (including Micro Crypto) 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 ADV 3,319 3,025 2,963 2,725 2,099 2,169 2,250 2
Slide 8: Use of Non-GAAP Measures; Forward-Looking Statements
2Q 2024 Earnings Commentary - Unaudited Use of Non-GAAP Measures A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of GAAP to non-GAAP Measures chart at the end of the financial statements and earnings presentation mate